I agree that is probably isn't a 'rort', but I find it strange how high the standards are here compared to the rest of the market.
Daybue is going to generate over half a billion dollars (in AU terms) in its first full year in a single country/market. It is the only approved drug and there is nothing immediately on the horizon. The part that isn't proven if this is 2-3bn peak sales drug, or if it's 1bn peak sales drug. We're not being valued at owning 10-15% + milestones on a 1bn peak sales drug, let alone more than that.
2591 has risk and needs to through more clinical trials but the results to date re-risk the asset significantly. We've been able to show the results that were so promising in animal models in Humans with stronger signals and improved safety compared to a drug which ultimately got approved. Best of all we're funded to do this ourselves (at least for a few indications).
- Forums
- ASX - By Stock
- NEU
- Stop the Rort (revisited)
Stop the Rort (revisited), page-9
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$14.05 |
Change
-0.510(3.50%) |
Mkt cap ! $1.795B |
Open | High | Low | Value | Volume |
$14.38 | $14.42 | $13.94 | $6.419M | 454.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $13.99 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.07 | 6644 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 13.990 |
1 | 300 | 13.970 |
1 | 1432 | 13.950 |
2 | 1230 | 13.900 |
1 | 720 | 13.890 |
Price($) | Vol. | No. |
---|---|---|
14.420 | 175 | 1 |
14.500 | 2985 | 2 |
14.800 | 2850 | 2 |
14.860 | 500 | 1 |
14.960 | 445 | 1 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |